Trial Profile
Safety and efficacy of capecitabine with or without sorafenib in patients with advanced/ metastatic breast cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 May 2016
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary) ; Capecitabine
- Indications Advanced breast cancer
- Focus Adverse reactions; Therapeutic Use
- 20 May 2016 New trial record